28 April 2017
Kromek Group plc
("Kromek" or the "Company" or the "Group")
Trading Update
Kromek, a radiation detection technology company focusing on the medical, security and nuclear markets, provides the following trading update for the year ending 30 April 2017 ahead of its full year results to be issued in July 2017.
The Group is making good progress on the delivery of new orders won over the past two years and, as a result, the Company is trading in line with market expectations.
The Group's products continue to gain traction in all its business segments from the increasing adoption of CZT-based technology and other products. The Group expects to continue to win new customers and, together with the momentum of contract wins, it expects a step change in revenue growth in the new financial calendar year.
Enquiries
Kromek Group plc |
01740 626 060 |
Arnab Basu, CEO Derek Bulmer, CFO |
|
|
|
Cenkos Securities plc |
0207 397 8900 |
Bobbie Hilliam (NOMAD) Harry Pardoe |
|
|
|
Luther Pendragon |
0207 618 9100 |
Harry Chathli, Claire Norbury, Alexis Gore |
|